1. https://www.onkopedia.com/de/onkopedia/guidelines/cup-syndrom-krebserkrankungen-mit-unbekanntem-primaertumor/@@view/html/index.html#head-protocols (letzter Zugriff 24.6.2023).
2. http://www.esmo.org/Guidelines/Cancers-of-Unknown-Primary-Site/Cancers-of- Unknown-Primary-Site (letzter Zugriff 24.6.2023).
3. Fizazi K, Maillard A, Penel N, et al. A phase 3 trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04). Ann Oncol, 2019:30 (suppl_5): v851-v934.
4. Greco FA, Erland JB, Morrissey LH, et al. Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin. Ann Oncol, 2000; 11: 211–215.
5. Greco FA, Pavlidis N. Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors. Semin Oncol, 2000; 36: 65–74.